Publication: Damage assessment in adult IgA vasculitis. Cross-sectional results of a multicentre cohort
| dc.contributor.authors | Gazel, U.; Colak, S.; Sari, A.; Cansu, D. U.; Yazici, A.; Cefle, A.; Bes, C.; Karadag, O.; Omma, A.; Direskeneli, H.; Alibaz-Oner, F. | |
| dc.date.accessioned | 2022-03-12T22:54:51Z | |
| dc.date.accessioned | 2026-01-11T08:05:40Z | |
| dc.date.available | 2022-03-12T22:54:51Z | |
| dc.date.issued | 2020 | |
| dc.description.abstract | Objective. Immunoglobulin (Ig) A vas-culitis affects children more commonly than adults and previous literature lacks any formal damage assessment. Our aim in this study is to investigate the disease course, relapse rates and prog-nostic factors in adult patients with IgA vasculitis and to evaluate the disease-related damage. Methods. We assembled a retrospective cohort of adult IgA vasculitis from six tertiary Rheumatology Centres in Turkey. The demographics, clinical characteris-tics, treatment and outcomes of patients were abstracted from medical records. Results. The study included 130 (male/female: 85/45) patients and the mean age was 42.2 +/- 17 years. Cutaneous manifestations and arthritis/arthralgia were the most common clinical mani-festations. One hundred thirteen pa-tients (86.9%) were treated with oral glucocorticoids (GC). As additional immunosuppressive (IS) agents, aza-thioprine was given to 44 (34.9%) and pulse cyclophosphamide to 18 (12.6%) patients. Seventy-nine patients (60%) had follow-up of median 15 (IQR 7-40) months. Twelve (15%) patients re-lapsed during follow-up. The mean VDI score was 0.4 in the last visit. Nineteen (24.7%) patients had at least one dam-age item at the end of follow-up. Most frequent damage items were renal 11 (42%), ocular 4 (15%) and cardiovas-cular 4 (15%). Conclusion. In this cohort the most fre-quent damage item was renal and was related to the disease itself. Damage score was higher in patients with more severe disease and treated more aggres-sively. Our results suggest that more ef-fective treatment options are needed in a subgroup of patients with IgA vasculitis to prevent the damage related with the vasculitis, especially with more severe disease. | |
| dc.identifier.doi | doiWOS:000571551900023 | |
| dc.identifier.eissn | 1593-098X | |
| dc.identifier.issn | 0392-856X | |
| dc.identifier.uri | https://hdl.handle.net/11424/236553 | |
| dc.identifier.wos | WOS:000571551900023 | |
| dc.language.iso | eng | |
| dc.publisher | CLINICAL & EXPER RHEUMATOLOGY | |
| dc.relation.ispartof | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | immunoglobulin A vasculitis | |
| dc.subject | Henoch Schonlein purpura | |
| dc.subject | damage | |
| dc.subject | prognosis | |
| dc.subject | leukocytoclastic vasculitis | |
| dc.subject | HENOCH-SCHONLEIN PURPURA | |
| dc.subject | PREDICTIVE FACTORS | |
| dc.subject | CLINICAL SPECTRUM | |
| dc.subject | GENE POLYMORPHISM | |
| dc.subject | RENAL INVOLVEMENT | |
| dc.subject | CHILDREN | |
| dc.subject | NEPHRITIS | |
| dc.subject | DISEASE | |
| dc.subject | MANIFESTATIONS | |
| dc.subject | PROGNOSIS | |
| dc.title | Damage assessment in adult IgA vasculitis. Cross-sectional results of a multicentre cohort | |
| dc.type | article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | S160 | |
| oaire.citation.issue | 2 | |
| oaire.citation.startPage | S155 | |
| oaire.citation.title | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | |
| oaire.citation.volume | 38 |
